Have you been diagnosed with non-small cell lung cancer? Have you already been treated with an anti PDL-1 therapy and chemotherapy? If so, you may be able to take part in a research study looking to compare the safety and effectiveness of the investigational drug RMC-6236 to docetaxel.

We are looking for adults ages 18 and up who are interested in using digital tools, a smartphone app, and text messages to help them make positive changes in their eating, activity, and weight.

We're looking into whether a dietary supplement from fish oils can ease ongoing jaw and face pain. These oils have ingredients that help calm inflammation and aid healing. By comparing this supplement to a placebo, which is just an inactive oil, we aim to see if the supplement can relieve chronic jaw pain and learn how it affects the body.

We're exploring how students use AI tools, like ChatGPT, to help with schoolwork and how colleges are responding. We want to know how these tools help students, especially those that are first in their family to attend college, in subjects like science and math. We'll collect information from schools on the kinds of rules they are putting in place. This way, we can understand better how AI is helping students and how colleges can support everyone fairly.

The purpose is to see if a drug, remibrutinib 25 mg twice a day, is safe and effective in treatment of peanut, milk or egg allergy.

We are doing a new study to better understand the experiences and beliefs of parents with daughters who have or had early puberty .

This study looks at how students, instructors, and staff in the humanities and social sciences think about and use generative AI tools like ChatGPT in their academic work. We are interested in how often people use these tools, what they use them for, and what concerns or questions they have. The goal is to better understand what kinds of guidance or support people may need as these tools become more common in higher education.

Do you enjoy using wearable tech? Do you drink alcohol? Join our study to help us learn which wearable alcohol sensors people prefer in their daily lives. You'll receive compensation for your time.

Are you a transgender or nonbinary young adult, ages 18-25, living in North Carolina? You may be eligible to take part in a research study exploring the experiences of TGNB young adults with gender-affirming care, including both the challenges and supports along the way. Participation involves a brief survey and an online interview (about 1.5-2 hours total). The interview will be scheduled at your convenience and conducted via Zoom. Compensation: $60 gift card

The purpose of this study is to compare the usual treatment alone (chemoradiation and pembrolizumab followed by pembrolizumab) to using induction chemotherapy therapy with pembrolizumab before chemoradiation and pembrolizumab followed by pembrolizumab. The addition of providing induction therapy (carboplatin, paclitaxel, and pembrolizumab) prior to the usual chemoradiation and pembrolizumab therapy could shrink your cancer or prevent it from returning